Social media users have been reacting to President Donald Trump’s championing of the use of hydroxychloroquine as a treatment for COVID-19, with some referring to a deal struck in 2017 between the pharmaceutical company Novartis, which makes the drug, and the president’s former lawyer Michael Cohen.
On Sunday night and Monday morning, Novartis, the Swiss pharmaceutical company that is a major manufacturer of the drug, started trending. Some referred to the company’s payment of $1.2 million to Trump’s former lawyer Michael Cohen for health care policy consulting work during a contract that was signed in 2017.
So Novartis and all these pharmaceutical companies are pushing hydroxychloroquine to make tons of money during a pandemic, exploiting people’s desperation for any possible cure. Trump is their salesman, doctors are their drug dealers, and the American people are the guinea pigs.
— Eugene Gu, MD (@eugenegu) April 6, 2020
Back on March 20th, Novartis announced it would donate 130 million doses of generic hydroxychloroquine.
Today Trump is saying the government will be purchasing the drug for the national stockpile.
Novartis is the same company Michael Cohen helped obtain access to Donald Trump.
— Rodney Caston (@RodneyCaston) April 5, 2020
When the president is pressed about chloroquines and why he’s pushing them it tends to devolve into him calling the question fake news.
— Maggie Haberman (@maggieNYT) April 5, 2020
The generic drug Trump keeps pushing as as an unverified, possibly unsafe treatment for COVID-19 was made by Novartis, who paid Michael Cohen $1.2 million to get access to Trump. https://t.co/xMrYT2M9Mx
— Swing Left (@swingleft) April 6, 2020